BioSpace News Archive

Wholly-owned LICA drug for beta-thalassemia, IONIS-TMPRSS6-L Rx, demonstrates therapeutic potential with positive modulation of important disease-related biomarkers and increase of serum hepcidin in initial clinical study

The VENTANA pan-TRK (EPR17341) Assay[1] is the first assay of its type to detect tropomyosin receptor kinase (TRK) with anticipated use across multiple solid tumor types

An Experienced Commercial Executive with Tenure at Industry Leaders Including Allergan, AbbVie, Zimmer Biomet and Recently with Dendreon’s Autologous Cell Therapy

Antibe Therapeutics Inc. is pleased to announce the successful completion of part one of the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346.

Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) to support the advancement of the Aethlon Hemopurifier® for the treatment of cancer.

NetraMark Corp. and Juvenescence Ltd. have partnered to form NetraPharma, a joint venture that is using artificial intelligence technologies to develop therapies that could slow, halt or potentially reverse aging.

Redemption eliminates annual cash dividend payment

Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.

Select customers with GE CT scanners can now access and seamlessly integrate MaxQ’s revolutionary brain bleed detection software into their workflow via Smart Subscription